Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogen Idec buys neurodegenerative disease rights

December 21, 2010
Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases

Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …

News

Congressman says FDA should scrutinise J&J’s manufacturing partners

December 21, 2010
Manufacturing and Production BestSweet, FDA, J&J, JJ, Johnson & Johnson, McNeil, Rolaids, manufacturing compliance, recalls

The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …

News

Scottish First Minister seeks talks with Aptuit over plant closures

December 21, 2010
Manufacturing and Production Aptuit, Scotland, manufacturing facilities, pharma manufacturing

US contract manufacturing and drug development company Aptuit says it may shut down two facilities in Lothian, Scotland, because demand …

News

CRM and software-as-a-service

December 21, 2010
Sales and Marketing CRM, Dan Goldsmith, Service Insight, Veeva Systems

Service Insight from Dan Goldsmith, general manager, Europe, Veeva SystemsCriminal mastermind, Frank Abagnale Jr. (1901-1980), successfully conned millions of dollars …

Feature

Contract research news in brief

December 20, 2010
Research and Development Biomodels, CIT, Charles River Laboratories, Dedicated Phase I, INC Research, PPD

Our round-up of recent development in the contract research sector includes updates from Charles River, CIT/Biomodels, INC Research, PPD and …

News
AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor)

FDA delays approval of AstraZeneca’s Brilinta

December 20, 2010
Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome

US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …

News

Italy OKs first large-scale unit for making radiolabelled peptides

December 20, 2010
Manufacturing and Production AIFA, Advanced Accelerator Applications, BioSynthema, Italy

The world’s first industrial-scale manufacturing facility for radiolabelled peptides used in nuclear medicine has been approved by the Italian Pharmaceutical …

News

Sanofi signs new oncology research deals

December 20, 2010
Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs

Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …

News

Aesica aims to double capacity and turnover with UCB plants

December 20, 2010
Manufacturing and Production Aesica, UCB, pharma manufacturing

UK contract manufacturer and ingredient supplier Aesica Pharmaceuticals is planning to double its production capacity with the acquisition of three …

News

CME Spotlight: Uniting European CME

December 20, 2010
Medical Communications CME, Continuing medical education, Eugene Pozniak

I started writing this month’s column while still in Berlin, one of my favourite cities in Europe, and also the …

Feature
georgeteague_refreshedwellbeing

Refreshed Wellbeing appoints new creative director

December 17, 2010
Medical Communications George Teague, Refreshed Wellbeing, appointment, medical communications

Reigate, UK-based healthcare comms agency Refreshed Wellbeing has appointed George Teague as creative director. His appointment comes at a time …

Appointment

Sanofi and Merck Serono to collaborate in oncology

December 17, 2010
Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis

Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …

News

Pharma careers options – management in China

December 17, 2010
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …

Feature

New hepatitis C drug offers cure for more patients

December 17, 2010
Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …

News

Chime launches new healthcare comms venture

December 17, 2010
Medical Communications Chime Communications, David Rowley, Sandy Royden, healthcare comms agency, medical communications

Communications giant Chime is putting money into a new healthcare PR venture which will be run by the ex-global head …

News

Government consults on UK value-based pricing

December 17, 2010
Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing

The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …

News

Merck KGaA appoints new head of pharma

December 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …

Appointment

Government pushes on with major NHS reforms

December 16, 2010
GP consortia, Health and Wellbeing Boards, NHS, NHS Commissioning Board, NHS Operating Framework, NHS reforms, PCTs

The government has set out a roadmap for its wide-ranging NHS reform plans that promises no let up in the …

News

Reforms are a ‘risky business’ for the NHS

December 16, 2010
Civitas, GP commissioning, NHS, NHS reforms, PCTs

The government is taking a ‘big risk’ with NHS reforms that will hand GPs responsibility for commissioning services, according to …

News
ABPI

Novo rebuked after diabetes promotion breaches Code

December 16, 2010
Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly

Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026